Status:
RECRUITING
Radiation Field, Dose and Fractionation Related to Mandibular Complications
Lead Sponsor:
Lund University Hospital
Conditions:
Head and Neck Neoplasms
Osteoradionecrosis
Eligibility:
All Genders
18+ years
Brief Summary
Radiotherapy is inhibiting the healing capacity of the mandibular bone. Late complications as bone exposure, fracture of the jaw, osteoradionecrosis might be a consequence of this vulnerability. A fac...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinical diagnosis of the head and neck malignancy
- Must have recieved radiotherapy as primary treatment alone or combination treatment together with surgery
- Exclusion criteria
- less than 12 months follow up
- Under 18 years of age
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05412849
Start Date
January 1 2023
End Date
July 1 2025
Last Update
May 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skane University Hospital
Lund, Sweden